In oral squamous cell carcinomas (OSCC), metformin decreased expression of YES1-associated transcriptional regulator (YAP), an effector of the Hippo signaling pathway, and YAP overexpression reduced metformin inhibition on mTOR and c-MYC expression [114]. Here, YAP1 is linked to oral cavity squamous cell carcinoma.